Trascriptional coactivator p300 plays an important role in differentiation processes of various cell lines. In this report, we examined levels of p300 protein and the related protein, CREB binding protein (CBP), during the retinoic acid (RA)-induced differentiation of F9 cell. As a result, the level of p300 protein began to decrease at 36 h after treatment with RA dramatically, however, the level of CBP protein did not alter.
INTRODUCTION
Transcriptional coactivator p300 was identified as a factor which associates with adenovirus E1A oncoprotein (1) and this factor is highly conserved with CBP which participates in the signal transduction by cyclic AMP (cAMP). It has been known that function of both p300 and CBP are a bridging factor between enhancer binding proteins and basal transcription factors and these coactivators have a histone acetyltransferase (HAT) activity which correlate a chromatin remodeling (2) . These two cofactors make contact with and connect the functions of so many well-studied proteins such as Jun, CREB, E1A, E2F, ATF-2 and nuclear hormone receptors (3, 4, 5) . Moreover, bi-allelic inactivating somatic mutations of p300 gene have been observed in gastric and colon cancers and a defect of one allele in the CBP gene iThe first two authors contributed equally to this work.
causes to Rubinstein-Taybi syndrome (RTS). Thus, p300 and CBP have functions as tumor suppresser proteins and intact levels of both proteins are important for many biological processes.
F9 murine embryonal carcinoma (EC) cell line can be induced to differentiate into primitive endoderm with treatment of retinoic acid (RA). Therefore, these cells constitute an attractive model system to study early events of mammalian development and retinoic signaling. In the analysis of p300-knock down cells using ribozymes, it has been shown the intact level of p300 protein is necessary for the RA-induced differentiation (6) . In addition, there is little known about an alternation of levels of these coactivators (7) .
In this report, we investigated alternation of levels of both p300 and CBP proteins during the RA-induced differentiation.
RESULTS AND DISCUSSION
To examine alternation of levels of p300 and CBP proteins during the RA-induced differentiation of F9 cells in detail, at first, we checked the relative levels of p300 and CBP protein during RA-induced differentiation using western blot analysis. We used p300-specific monoclonal antibodies RW102 or RW128 or CBP-specific monoclonal antibodies AC238 or AC26. As a result, the level of p300 pfotein began to decrease at 36 h after treatment with RA (Fig. 1 ). In contrast, the level of CBP protein was not changed drastically. In addition, we know that levels of both coactivator mRNAs did not alter in the presence or absence of RA significantly. These results indicate that the decreased of level p300 protein is not caused by the regulation of transcription, but post-translational processes.
In the regulation of post-translational processes, many proteins associated with the tumor suppresser protein p53 are degraded through the formation of ubiquitin-protein complexes targeted by 26S proteasome (8) . To examine whether the degradation of p300 protein is controled by ubiquitin-dependent proteolysis system, we performed the immunoprecipitation (IP)-western blot analysis to detect the ubiqutinated p300 protein. In differentiated F9 cells, the ubiquitinated p300 protein were detected by the specific antibody against the ubiquitin. By contrast, the ubiquitination of p300 protein was not detect in undifferentiated F9 cells. Less ubiquitinted CBP protein was detected in differentiated F9 cells. These results indicate that p300 protein is degraded possibly via the ubiquitin-dependent proteolysis system.
We have previously reported that p300 protein began to appear as hyper-phosphorylated form at 36 h after treatment with RA (9). The biological significance of this hyper-phosphorylation of p300 is still unknown. Since a modification such as a phosphorylation is the target of ubiquitination, the hyper-phosphorylation of p300 may be also the target of the ubiqutination. In the present study, indeed, both degradation and ubiquitination of the p300 protein began to be detected in F9 cells after 36 h treatment with RA. Therefore, hyper-phosphorylation of p300 protein can be possible to correlate with the degradation by the ubiquitin-dependent proteolysis system. In addition, many putative sites which are phosphorylated by mitogen activated protein (MAP) kinase or cyclin/cdk complexes exist in amino acid sequences of p300. Moreover it has been reported that cyclinE-cdc2 complex or pp90 RSK interact with the carboxyl-terminal region of both p300 and CBP (10, 11) . We are now examining the molecular correlation between hyper-phosphorylation of p300 and ubiquitination of p300 during RA induced diferentiation. 
